- €559.07m
- €486.87m
- €493.25m
- 94
- 58
- 37
- 71
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 557 | 514 | 455 | 534 | 493 |
Cost of Revenue | |||||
Gross Profit | 430 | 395 | 328 | 380 | 358 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 490 | 475 | 409 | 472 | 449 |
Operating Profit | 66.9 | 38.2 | 46.7 | 61.9 | 43.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 64.4 | 37.2 | 46.1 | 59.2 | 46.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 40.6 | 26.2 | 28.6 | 44.3 | 33.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 40.6 | 26.2 | 28.6 | 44.7 | 35.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 40.6 | 26.2 | 28.6 | 44.7 | 35.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.43 | 1.5 | 1.64 | 2.55 | 2.15 |
Dividends per Share | |||||
Special Dividends per Share |